Zhongshan Hospital, formerly Chung Shan Memorial Hospital, is a major teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.

During the past decade, Zhongshan Hospital Affiliated to Fudan University conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 3 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 1 clinical trials were completed. i.e. 2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongshan Hospital Affiliated to Fudan University" #1 sponsor was "Shanghai Zhongshan Hospital" with 18 trials, followed by "BeiGene" with 9 trials sponsored, "Fudan University" with 5 trials sponsored, "Pfizer" with 3 trials sponsored and "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Hospital Affiliated to Fudan University" #1 collaborator was "Shanghai Zhongshan Hospital" with 13 trials as a collaborator, "Anhui Provincial Hospital" with 5 trials as a collaborator, "Ruijin Hospital" with 5 trials as a collaborator, "Changhai Hospital" with 3 trials as a collaborator and "Fudan University" with 3 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Zhongshan Hospital Affiliated to Fudan University" are "Hepatocellular Carcinoma" (5 trials), "Gastric Adenocarcinoma" (3 trials), "Advanced Solid Tumors" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Zhongshan Hospital Affiliated to Fudan University" in a lesser frequency.

Most popular intervention types in "Zhongshan Hospital Affiliated to Fudan University" are "Drug" (63 trials), "Procedure" (16 trials), "Device" (9 trials), "Biological" (7 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Tislelizumab" (9 trials), "Cisplatin" (5 trials), "Docetaxel" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Zhongshan Hospital Affiliated to Fudan University" are 89 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 48 active trials in "Zhongshan Hospital Affiliated to Fudan University". 3 are not yet recruiting, 34 are recruiting, 7 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 15 completed trials in Zhongshan Hospital Affiliated to Fudan University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Zhongshan Hospital Affiliated to Fudan University, 14 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".